These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2427494)

  • 1. Effects of bleomycin on Burkitt lymphoma cells grown in vitro and in vivo.
    Miyamoto T; Terasima T
    Jpn J Cancer Res; 1986 Jul; 77(7):674-81. PubMed ID: 2427494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleomycin induced changes in growth and cell kinetics of a heterotransplanted squamous cell carcinoma of the head and neck.
    Wennerberg J
    Anticancer Res; 1984; 4(6):419-23. PubMed ID: 6083742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lethal effect of bleomycin on Burkitt lymphoma cells at stationary phase].
    Miyamoto T; Terasima T
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):652-9. PubMed ID: 6191701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dependence of bleomycin-induced cytotoxicity and DNA damage on the in vitro culture growth phase of mouse tumour cells.
    Mircheva JJ
    Acta Physiol Pharmacol Bulg; 1987; 13(3):75-80. PubMed ID: 2449799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on recovery from chemically induced damage in mammalian cells.
    Barranco SC; Novak JK; Humphrey RM
    Cancer Res; 1975 May; 35(5):1194-204. PubMed ID: 47265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular distribution of (14C)bleomycin and the cytokinetic effects of bleomycin in the mouse tumor.
    Fujimoto J; Higashi H; Kosaki G
    Cancer Res; 1976 Jul; 36(7 PT 1):2248-53. PubMed ID: 58717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
    Tanaka N
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2666-73. PubMed ID: 6210060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of bleomycin-resistant phenotypes of human cell sublines and circumvention of bleomycin resistance by liblomycin.
    Lazo JS; Braun ID; Labaree DC; Schisselbauer JC; Meandzija B; Newman RA; Kennedy KA
    Cancer Res; 1989 Jan; 49(1):185-90. PubMed ID: 2461797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of glutathione levels in rodent and human tumor cells grown in vitro and in vivo.
    Allalunis-Turner MJ; Lee FY; Siemann DW
    Cancer Res; 1988 Jul; 48(13):3657-60. PubMed ID: 3378208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic inactivation: a mechanism of human tumor resistance to bleomycin.
    Sebti SM; Jani JP; Mistry JS; Gorelik E; Lazo JS
    Cancer Res; 1991 Jan; 51(1):227-32. PubMed ID: 1703034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lidocaine potentiation of bleomycin A2 cytotoxicity and DNA strand breakage in L1210 and human A-253 cells.
    Lazo JS; Braun ID; Meandzija B; Kennedy KA; Pham ET; Smaldone LF
    Cancer Res; 1985 May; 45(5):2103-9. PubMed ID: 2580616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermla cell kinetics in hairless mice after bleomycin. I. Perturbations after different single doses.
    Thorud E; Clausen OP
    Cancer Treat Rep; 1978 Mar; 62(3):351-61. PubMed ID: 77187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery from potentially lethal damage and recruitment time of noncycling clonogenic cells in 9L confluent monolayers and spheroids.
    Rodriguez A; Alpen EL; Mendonca M; DeGuzman RJ
    Radiat Res; 1988 Jun; 114(3):515-27. PubMed ID: 3375440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in the sensitivity of EMT6/VJAC cells to bleomycin and hyperthermia due to the growth phase of the cell culture].
    Mircheva I; Smith P; Bleehen NM
    Eksp Med Morfol; 1986; 25(4):11-6. PubMed ID: 2434301
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytotoxic and cell kinetic effects of 3,4,5-trihydroxybenzohydroxamic acid (VF 122) in hepatoma 3924A cells.
    Ban J; Olah E; Weber G
    Cancer Treat Rep; 1982 Dec; 66(12):2071-80. PubMed ID: 7139648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of 9L tumor cells in vitro to spirohydantoin mustard.
    Deen DF; Hoshino T; Williams ME; Nomura K; Bartle PM
    Cancer Res; 1979 Nov; 39(11):4336-40. PubMed ID: 498067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose fractionation effects in plateau-phase cultures of C3H 10T1/2 cells and their transformed counterparts.
    Zeman EM; Bedford JS
    Radiat Res; 1985 Feb; 101(2):373-93. PubMed ID: 3975362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromatin condensation and differential sensitivity of mammalian and insect cells to DNA strand breaks induced by bleomycin.
    López-Larraza DM; Padrón J; Ronci NE; Vidal Rioja LA
    Mutat Res; 2006 Aug; 600(1-2):93-101. PubMed ID: 16620879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of combined treatments with low hyperthermia and bleomycin on survivals of murine L cells.
    Shioura H; Hayashi S; Matsumoto H; Kitai R; Ohtsubo T; Nishida T; Zhang SW; Yoshida M; Ishii Y; Kano E
    J Exp Clin Cancer Res; 1997 Jun; 16(2):147-52. PubMed ID: 9261739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.
    Burres NS; Clement JJ
    Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.